{"id":"W4324057396","doi":"10.25251/skin.7.2.5","title":"Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3","year":2023,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"LEO Pharma; Galderma; Ortho Dermatologics; Valeant Pharmaceuticals International; Celgene; GlaxoSmithKline; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Post-hoc analysis; Placebo; Eczema Area and Severity Index; Medicine; Atopic dermatitis; Population; Randomized controlled trial; Adverse effect; Internal medicine; Dermatology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006070726,0.001021259,0.001842301,0.0002914481,0.0003882195,0.000730219,0.0006167985,0.0006517385,0.004234843],"category_scores_gemma":[0.004368915,0.0002743592,0.004307839,0.0003206637,0.0004882044,0.000652223,0.0004846825,0.001414724,0.0005364512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007560703,"about_ca_system_score_gemma":0.001267875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001182097,"about_ca_topic_score_gemma":0.002220066,"domain_scores_codex":[0.9970915,0.001715675,0.0001983772,0.0003726514,0.0003063768,0.0003152644],"domain_scores_gemma":[0.9962983,0.001628138,0.0007204337,0.0005051037,0.0004743603,0.0003737299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9252101,0.004996618,0.0313687,0.0005744389,0.009358701,0.0001546285,0.0001730113,0.001296458,0.007447498,0.00009283634,0.002070506,0.01725646],"study_design_scores_gemma":[0.1556116,0.4196416,0.3667254,0.0001212211,0.0269142,0.0006091194,0.0003478942,0.009259015,0.01452426,0.0003401399,0.005788003,0.0001176096],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962505,0.0007995402,0.0003520654,0.0001039989,0.00005982694,0.0005161888,0.001080745,0.00002547062,0.0008115954],"genre_scores_gemma":[0.996892,0.0001887145,0.0004177345,0.0001919123,0.00006135654,0.0004629562,0.001076007,0.00001294796,0.0006963733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006070726,"threshold_uncertainty_score":0.03210539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006425292969851087,"score_gpt":0.2508883681065757,"score_spread":0.2444630751367246,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}